世界の細胞毒性薬市場予測 2020年-2025年

【英語タイトル】Global Cytotoxic Drug Market Growth 2020-2025

LP Informationが出版した調査資料(LPI20AP1980)・商品コード:LPI20AP1980
・発行会社(調査会社):LP Information
・発行日:2020年3月30日(※2024年版があります。お問い合わせください)
・ページ数:163
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
「細胞毒性薬の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、注射剤、固形経口剤、その他など、用途別には、乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他などに区分してまとめた調査レポートです。細胞毒性薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・細胞毒性薬の世界市場概要(サマリー)
・細胞毒性薬の企業別販売量・売上
・細胞毒性薬の企業別市場シェア
・細胞毒性薬の世界市場規模 2015年-2020年:種類別(注射剤、固形経口剤、その他)
・細胞毒性薬の世界市場規模 2015年-2020年:用途別(乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他)
・細胞毒性薬の米州市場規模(アメリカ、カナダ、メキシコなど)
・細胞毒性薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・細胞毒性薬の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・細胞毒性薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・細胞毒性薬市場の成長要因・課題・動向
・細胞毒性薬の世界市場予測 2021年-2025年
・細胞毒性薬の米州市場予測(アメリカ、カナダ、メキシコなど)
・細胞毒性薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・細胞毒性薬の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・細胞毒性薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・細胞毒性薬の世界市場予測:種類別(注射剤、固形経口剤、その他)
・細胞毒性薬の世界市場予測:用途別(乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Cytotoxic Drug market will register a 1.0% CAGR in terms of revenue, the global market size will reach $ 14450 million by 2025, from $ 13870 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cytotoxic Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cytotoxic Drug market by type, application, key manufacturers and key regions and countries.

This study considers the Cytotoxic Drug value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Injection
Solid Oral Dose Forms
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Haosoh Pharma
Eli Lilly
Sanofi
eisai
Celgene
Seattle Genetics
Sumitomo Dainippon Pharma
Takeda
Merck
Novartis
Spectrum Pharma
Jazz Pharma
AstraZeneca

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cytotoxic Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cytotoxic Drug market by identifying its various subsegments.
Focuses on the key global Cytotoxic Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cytotoxic Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cytotoxic Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cytotoxic Drug Consumption 2015-2025
2.1.2 Cytotoxic Drug Consumption CAGR by Region
2.2 Cytotoxic Drug Segment by Type
2.2.1 Injection
2.2.2 Solid Oral Dose Forms
2.2.3 Others
2.3 Cytotoxic Drug Consumption by Type
2.3.1 Global Cytotoxic Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Cytotoxic Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cytotoxic Drug Sale Price by Type (2015-2020)
2.4 Cytotoxic Drug Segment by Application
2.4.1 Breast Cancer
2.4.2 Blood Cancer
2.4.3 Prostate Cancer
2.4.4 Respiratory/Lung Cancer
2.4.5 Other
2.5 Cytotoxic Drug Consumption by Application
2.5.1 Global Cytotoxic Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Cytotoxic Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Cytotoxic Drug Sale Price by Type (2015-2020)

3 Global Cytotoxic Drug by Company
3.1 Global Cytotoxic Drug Sales Market Share by Company
3.1.1 Global Cytotoxic Drug Sales by Company (2018-2020)
3.1.2 Global Cytotoxic Drug Sales Market Share by Company (2018-2020)
3.2 Global Cytotoxic Drug Revenue Market Share by Company
3.2.1 Global Cytotoxic Drug Revenue by Company (2018-2020)
3.2.2 Global Cytotoxic Drug Revenue Market Share by Company (2018-2020)
3.3 Global Cytotoxic Drug Sale Price by Company
3.4 Global Cytotoxic Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cytotoxic Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cytotoxic Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cytotoxic Drug by Regions
4.1 Cytotoxic Drug by Regions
4.2 Americas Cytotoxic Drug Consumption Growth
4.3 APAC Cytotoxic Drug Consumption Growth
4.4 Europe Cytotoxic Drug Consumption Growth
4.5 Middle East & Africa Cytotoxic Drug Consumption Growth

5 Americas
5.1 Americas Cytotoxic Drug Consumption by Countries
5.1.1 Americas Cytotoxic Drug Consumption by Countries (2015-2020)
5.1.2 Americas Cytotoxic Drug Value by Countries (2015-2020)
5.2 Americas Cytotoxic Drug Consumption by Type
5.3 Americas Cytotoxic Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cytotoxic Drug Consumption by Regions
6.1.1 APAC Cytotoxic Drug Consumption by Regions (2015-2020)
6.1.2 APAC Cytotoxic Drug Value by Regions (2015-2020)
6.2 APAC Cytotoxic Drug Consumption by Type
6.3 APAC Cytotoxic Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Cytotoxic Drug by Countries
7.1.1 Europe Cytotoxic Drug Consumption by Countries (2015-2020)
7.1.2 Europe Cytotoxic Drug Value by Countries (2015-2020)
7.2 Europe Cytotoxic Drug Consumption by Type
7.3 Europe Cytotoxic Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cytotoxic Drug by Countries
8.1.1 Middle East & Africa Cytotoxic Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cytotoxic Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Cytotoxic Drug Consumption by Type
8.3 Middle East & Africa Cytotoxic Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cytotoxic Drug Distributors
10.3 Cytotoxic Drug Customer

11 Global Cytotoxic Drug Market Forecast
11.1 Global Cytotoxic Drug Consumption Forecast (2021-2025)
11.2 Global Cytotoxic Drug Forecast by Regions
11.2.1 Global Cytotoxic Drug Forecast by Regions (2021-2025)
11.2.2 Global Cytotoxic Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cytotoxic Drug Forecast by Type
11.8 Global Cytotoxic Drug Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Cytotoxic Drug Product Offered
12.1.3 Roche Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 Haosoh Pharma
12.2.1 Company Information
12.2.2 Cytotoxic Drug Product Offered
12.2.3 Haosoh Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Haosoh Pharma Latest Developments
12.3 Eli Lilly
12.3.1 Company Information
12.3.2 Cytotoxic Drug Product Offered
12.3.3 Eli Lilly Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 Sanofi
12.4.1 Company Information
12.4.2 Cytotoxic Drug Product Offered
12.4.3 Sanofi Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 eisai
12.5.1 Company Information
12.5.2 Cytotoxic Drug Product Offered
12.5.3 eisai Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 eisai Latest Developments
12.6 Celgene
12.6.1 Company Information
12.6.2 Cytotoxic Drug Product Offered
12.6.3 Celgene Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Celgene Latest Developments
12.7 Seattle Genetics
12.7.1 Company Information
12.7.2 Cytotoxic Drug Product Offered
12.7.3 Seattle Genetics Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Seattle Genetics Latest Developments
12.8 Sumitomo Dainippon Pharma
12.8.1 Company Information
12.8.2 Cytotoxic Drug Product Offered
12.8.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sumitomo Dainippon Pharma Latest Developments
12.9 Takeda
12.9.1 Company Information
12.9.2 Cytotoxic Drug Product Offered
12.9.3 Takeda Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Takeda Latest Developments
12.10 Merck
12.10.1 Company Information
12.10.2 Cytotoxic Drug Product Offered
12.10.3 Merck Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Merck Latest Developments
12.11 Novartis
12.11.1 Company Information
12.11.2 Cytotoxic Drug Product Offered
12.11.3 Novartis Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Novartis Latest Developments
12.12 Spectrum Pharma
12.12.1 Company Information
12.12.2 Cytotoxic Drug Product Offered
12.12.3 Spectrum Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Spectrum Pharma Latest Developments
12.13 Jazz Pharma
12.13.1 Company Information
12.13.2 Cytotoxic Drug Product Offered
12.13.3 Jazz Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Jazz Pharma Latest Developments
12.14 AstraZeneca
12.14.1 Company Information
12.14.2 Cytotoxic Drug Product Offered
12.14.3 AstraZeneca Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 AstraZeneca Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Cytotoxic Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Injection
Table 5. Major Players of Solid Oral Dose Forms
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Cytotoxic Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Cytotoxic Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Cytotoxic Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Cytotoxic Drug Value by Application (2015-2020)
Table 15. Global Cytotoxic Drug Value Market Share by Application (2015-2020)
Table 16. Global Cytotoxic Drug Sale Price by Application (2015-2020)
Table 17. Global Cytotoxic Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Cytotoxic Drug Sales Market Share by Company (2017-2019)
Table 19. Global Cytotoxic Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Cytotoxic Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Cytotoxic Drug Sale Price by Company (2017-2019)
Table 22. Global Cytotoxic Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Cytotoxic Drug Products Offered
Table 24. Cytotoxic Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Cytotoxic Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Cytotoxic Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Cytotoxic Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Cytotoxic Drug Value Market Share by Regions 2015-2020
Table 29. Americas Cytotoxic Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Cytotoxic Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Cytotoxic Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Cytotoxic Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Cytotoxic Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Cytotoxic Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Cytotoxic Drug Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Cytotoxic Drug Consumption Market Share by Countries (2015-2020)
Table 39. APAC Cytotoxic Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Cytotoxic Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Cytotoxic Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Cytotoxic Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Cytotoxic Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Cytotoxic Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Cytotoxic Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Cytotoxic Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Cytotoxic Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Cytotoxic Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Cytotoxic Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Cytotoxic Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Cytotoxic Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Cytotoxic Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cytotoxic Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Cytotoxic Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Table 61. Cytotoxic Drug Distributors List
Table 62. Cytotoxic Drug Customer List
Table 63. Global Cytotoxic Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Cytotoxic Drug Consumption Market Forecast by Regions
Table 65. Global Cytotoxic Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Cytotoxic Drug Value Market Share Forecast by Regions
Table 67. Global Cytotoxic Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Cytotoxic Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Cytotoxic Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Cytotoxic Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Cytotoxic Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Cytotoxic Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Cytotoxic Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Cytotoxic Drug Value Market Share Forecast by Application (2021-2025)
Table 75. Roche Product Offered
Table 76. Roche Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. Roche Main Business
Table 78. Roche Latest Developments
Table 79. Roche Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Haosoh Pharma Product Offered
Table 81. Haosoh Pharma Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Haosoh Pharma Main Business
Table 83. Haosoh Pharma Latest Developments
Table 84. Haosoh Pharma Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Eli Lilly Product Offered
Table 86. Eli Lilly Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Eli Lilly Main Business
Table 88. Eli Lilly Latest Developments
Table 89. Eli Lilly Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Sanofi Product Offered
Table 91. Sanofi Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Sanofi Main Business
Table 93. Sanofi Latest Developments
Table 94. Sanofi Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. eisai Product Offered
Table 96. eisai Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. eisai Main Business
Table 98. eisai Latest Developments
Table 99. eisai Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Celgene Product Offered
Table 101. Celgene Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Celgene Main Business
Table 103. Celgene Latest Developments
Table 104. Celgene Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Seattle Genetics Product Offered
Table 106. Seattle Genetics Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Seattle Genetics Main Business
Table 108. Seattle Genetics Latest Developments
Table 109. Seattle Genetics Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Sumitomo Dainippon Pharma Product Offered
Table 111. Sumitomo Dainippon Pharma Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Sumitomo Dainippon Pharma Main Business
Table 113. Sumitomo Dainippon Pharma Latest Developments
Table 114. Sumitomo Dainippon Pharma Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Takeda Product Offered
Table 116. Takeda Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Takeda Main Business
Table 118. Takeda Latest Developments
Table 119. Takeda Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Merck Product Offered
Table 121. Merck Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Merck Main Business
Table 123. Merck Latest Developments
Table 124. Merck Basic Information, Company Total Revenue (in $ million), Cytotoxic Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis Product Offered
Table 126. Novartis Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Novartis Main Business
Table 128. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Latest Developments
Table 130. Spectrum Pharma Product Offered
Table 131. Spectrum Pharma Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Spectrum Pharma Main Business
Table 133. Spectrum Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Spectrum Pharma Latest Developments
Table 135. Jazz Pharma Product Offered
Table 136. Jazz Pharma Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Jazz Pharma Main Business
Table 138. Jazz Pharma Latest Developments
Table 139. Jazz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. AstraZeneca Product Offered
Table 141. AstraZeneca Cytotoxic Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. AstraZeneca Main Business
Table 143. AstraZeneca Latest Developments
Table 144. AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cytotoxic Drug
Figure 2. Cytotoxic Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cytotoxic Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Cytotoxic Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Injection
Figure 7. Product Picture of Solid Oral Dose Forms
Figure 8. Product Picture of Others
Figure 9. Global Cytotoxic Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Cytotoxic Drug Value Market Share by Type (2015-2020)
Figure 11. Cytotoxic Drug Consumed in Breast Cancer
Figure 12. Global Cytotoxic Drug Market: Breast Cancer (2015-2020) (K Units)
Figure 13. Global Cytotoxic Drug Market: Breast Cancer (2015-2020) ($ Millions)
Figure 14. Cytotoxic Drug Consumed in Blood Cancer
Figure 15. Global Cytotoxic Drug Market: Blood Cancer (2015-2020) (K Units)
Figure 16. Global Cytotoxic Drug Market: Blood Cancer (2015-2020) ($ Millions)
Figure 17. Cytotoxic Drug Consumed in Prostate Cancer
Figure 18. Global Cytotoxic Drug Market: Prostate Cancer (2015-2020) (K Units)
Figure 19. Global Cytotoxic Drug Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 20. Cytotoxic Drug Consumed in Respiratory/Lung Cancer
Figure 21. Global Cytotoxic Drug Market: Respiratory/Lung Cancer (2015-2020) (K Units)
Figure 22. Global Cytotoxic Drug Market: Respiratory/Lung Cancer (2015-2020) ($ Millions)
Figure 23. Cytotoxic Drug Consumed in Other
Figure 24. Global Cytotoxic Drug Market: Other (2015-2020) (K Units)
Figure 25. Global Cytotoxic Drug Market: Other (2015-2020) ($ Millions)
Figure 26. Global Cytotoxic Drug Consumption Market Share by Application (2015-2020)
Figure 27. Global Cytotoxic Drug Value Market Share by Application (2015-2020)
Figure 28. Global Cytotoxic Drug Sales Market Share by Company in 2017
Figure 29. Global Cytotoxic Drug Sales Market Share by Company in 2019
Figure 30. Global Cytotoxic Drug Revenue Market Share by Company in 2017
Figure 31. Global Cytotoxic Drug Revenue Market Share by Company in 2019
Figure 32. Global Cytotoxic Drug Sale Price by Company in 2019
Figure 33. Global Cytotoxic Drug Consumption Market Share by Regions 2015-2020
Figure 34. Global Cytotoxic Drug Value Market Share by Regions 2015-2020
Figure 35. Americas Cytotoxic Drug Consumption 2015-2020 (K Units)
Figure 36. Americas Cytotoxic Drug Value 2015-2020 ($ Millions)
Figure 37. APAC Cytotoxic Drug Consumption 2015-2020 (K Units)
Figure 38. APAC Cytotoxic Drug Value 2015-2020 ($ Millions)
Figure 39. Europe Cytotoxic Drug Consumption 2015-2020 (K Units)
Figure 40. Europe Cytotoxic Drug Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Cytotoxic Drug Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Cytotoxic Drug Value 2015-2020 ($ Millions)
Figure 43. Americas Cytotoxic Drug Consumption Market Share by Countries in 2019
Figure 44. Americas Cytotoxic Drug Value Market Share by Countries in 2019
Figure 45. Americas Cytotoxic Drug Consumption Market Share by Type in 2019
Figure 46. Americas Cytotoxic Drug Consumption Market Share by Application in 2019
Figure 47. United States Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 48. United States Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Cytotoxic Drug Consumption Market Share by Countries in 2019
Figure 54. APAC Cytotoxic Drug Value Market Share by Regions in 2019
Figure 55. APAC Cytotoxic Drug Consumption Market Share by Type in 2019
Figure 56. APAC Cytotoxic Drug Consumption Market Share by Application in 2019
Figure 57. China Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 58. China Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 65. India Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 66. India Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Cytotoxic Drug Consumption Market Share by Countries in 2019
Figure 70. Europe Cytotoxic Drug Value Market Share by Countries in 2019
Figure 71. Europe Cytotoxic Drug Consumption Market Share by Type in 2019
Figure 72. Europe Cytotoxic Drug Consumption Market Share by Application in 2019
Figure 73. Germany Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 75. France Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 76. France Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 77. UK Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 78. UK Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 83. Spain Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 84. Spain Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 85. Middle East & Africa Cytotoxic Drug Consumption Market Share by Countries in 2019
Figure 86. Middle East & Africa Cytotoxic Drug Value Market Share by Countries in 2019
Figure 87. Middle East & Africa Cytotoxic Drug Consumption Market Share by Type in 2019
Figure 88. Middle East & Africa Cytotoxic Drug Consumption Market Share by Application in 2019
Figure 89. Egypt Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 90. Egypt Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 91. South Africa Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 92. South Africa Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 93. Israel Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 94. Israel Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 95. Turkey Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 96. Turkey Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 97. GCC Countries Cytotoxic Drug Consumption Growth 2015-2020 (K Units)
Figure 98. GCC Countries Cytotoxic Drug Value Growth 2015-2020 ($ Millions)
Figure 99. Global Cytotoxic Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 100. Global Cytotoxic Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 101. Americas Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 102. Americas Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 103. APAC Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 104. APAC Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 105. Europe Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 106. Europe Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 107. Middle East & Africa Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 108. Middle East & Africa Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 109. United States Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 110. United States Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 111. Canada Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 112. Canada Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 113. Mexico Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 114. Mexico Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 115. Brazil Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 116. Brazil Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 117. China Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 118. China Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 119. Japan Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 120. Japan Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 121. Korea Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 122. Korea Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 123. Southeast Asia Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 124. Southeast Asia Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 125. India Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 126. India Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 127. Australia Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 128. Australia Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 129. Germany Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 130. Germany Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 131. France Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 132. France Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 133. UK Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 134. UK Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 135. Italy Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 136. Italy Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 137. Russia Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 138. Russia Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 139. Spain Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 140. Spain Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 141. Egypt Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 142. Egypt Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 143. South Africa Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 144. South Africa Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 145. Israel Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 146. Israel Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 147. Turkey Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 148. Turkey Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 149. GCC Countries Cytotoxic Drug Consumption 2021-2025 (K Units)
Figure 150. GCC Countries Cytotoxic Drug Value 2021-2025 ($ Millions)
Figure 151. Roche Cytotoxic Drug Market Share (2018-2020)
Figure 152. Haosoh Pharma Cytotoxic Drug Market Share (2018-2020)
Figure 153. Eli Lilly Cytotoxic Drug Market Share (2018-2020)
Figure 154. Sanofi Cytotoxic Drug Market Share (2018-2020)
Figure 155. eisai Cytotoxic Drug Market Share (2018-2020)
Figure 156. Celgene Cytotoxic Drug Market Share (2018-2020)
Figure 157. Seattle Genetics Cytotoxic Drug Market Share (2018-2020)
Figure 158. Sumitomo Dainippon Pharma Cytotoxic Drug Market Share (2018-2020)
Figure 159. Takeda Cytotoxic Drug Market Share (2018-2020)
Figure 160. Merck Cytotoxic Drug Market Share (2018-2020)
Figure 161. Novartis Cytotoxic Drug Market Share (2018-2020)
Figure 162. Spectrum Pharma Cytotoxic Drug Market Share (2018-2020)
Figure 163. Jazz Pharma Cytotoxic Drug Market Share (2018-2020)
Figure 164. AstraZeneca Cytotoxic Drug Market Share (2018-2020)


★調査レポート[世界の細胞毒性薬市場予測 2020年-2025年] (コード:LPI20AP1980)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞毒性薬市場予測 2020年-2025年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆